GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 907 filers reported holding GLAXOSMITHKLINE PLC in Q4 2021. The put-call ratio across all filers is 0.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,192,000 | -54.2% | 27,372 | -54.2% | 0.04% | -47.0% |
| Q1 2022 | $2,601,000 | +12.6% | 59,707 | +14.0% | 0.08% | +20.3% |
| Q4 2021 | $2,310,000 | +15.6% | 52,381 | +0.1% | 0.07% | +7.8% |
| Q3 2021 | $1,998,000 | -3.4% | 52,316 | +0.7% | 0.06% | -3.0% |
| Q2 2021 | $2,069,000 | +11.1% | 51,957 | -0.5% | 0.07% | +4.8% |
| Q1 2021 | $1,863,000 | -27.0% | 52,222 | -24.7% | 0.06% | -30.8% |
| Q4 2020 | $2,553,000 | -31.6% | 69,393 | -22.3% | 0.09% | -60.4% |
| Q1 2019 | $3,733,000 | -1.1% | 89,313 | -9.6% | 0.23% | -11.9% |
| Q4 2018 | $3,773,000 | +11.1% | 98,755 | +16.8% | 0.26% | +29.9% |
| Q3 2018 | $3,396,000 | +2.6% | 84,537 | +3.0% | 0.20% | -2.4% |
| Q2 2018 | $3,309,000 | +5.0% | 82,091 | +1.8% | 0.21% | +1.5% |
| Q1 2018 | $3,151,000 | +0.5% | 80,645 | -8.8% | 0.20% | 0.0% |
| Q4 2017 | $3,135,000 | -6.9% | 88,387 | +6.5% | 0.20% | -12.9% |
| Q3 2017 | $3,369,000 | -1.8% | 82,976 | +4.3% | 0.23% | -6.4% |
| Q2 2017 | $3,432,000 | +6.2% | 79,585 | +3.9% | 0.25% | 0.0% |
| Q1 2017 | $3,231,000 | +23.2% | 76,629 | +12.5% | 0.25% | +15.3% |
| Q4 2016 | $2,622,000 | +5.3% | 68,096 | +17.9% | 0.22% | +1.4% |
| Q3 2016 | $2,491,000 | +14.3% | 57,760 | +14.9% | 0.21% | +9.2% |
| Q2 2016 | $2,179,000 | +6.7% | 50,281 | -0.2% | 0.20% | +4.3% |
| Q1 2016 | $2,042,000 | +1.5% | 50,357 | +1.0% | 0.19% | +2.2% |
| Q4 2015 | $2,011,000 | +5.3% | 49,850 | +0.3% | 0.18% | +1.1% |
| Q3 2015 | $1,910,000 | +84.9% | 49,683 | +100.4% | 0.18% | +90.5% |
| Q2 2015 | $1,033,000 | -13.5% | 24,796 | -4.2% | 0.10% | -16.7% |
| Q1 2015 | $1,194,000 | +58.1% | 25,882 | +46.5% | 0.11% | +50.0% |
| Q4 2014 | $755,000 | -8.8% | 17,666 | -1.9% | 0.08% | -11.6% |
| Q3 2014 | $828,000 | +27.4% | 18,007 | +48.2% | 0.09% | +30.3% |
| Q2 2014 | $650,000 | -0.3% | 12,152 | -0.4% | 0.07% | -5.7% |
| Q1 2014 | $652,000 | -1.2% | 12,203 | -1.3% | 0.07% | -5.4% |
| Q4 2013 | $660,000 | +6.6% | 12,367 | +0.3% | 0.07% | -5.1% |
| Q3 2013 | $619,000 | -1.4% | 12,336 | -1.8% | 0.08% | -8.2% |
| Q2 2013 | $628,000 | – | 12,559 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |